GLYCOMAX
LIVE

Serial Number

79200172

Owner

Probiotec Limited

Attorney

Jeffrey H. Greger

Filing Date

Aug 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

GLYCOMAX Trademark

Serial Number: 79200172 • Registration: 5515976

GLYCOMAX is a trademark filed by Probiotec Limited on August 24, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Probiotec Limited (2 trademarks)

83 Cherry Lane

Entity Type: 03

Trademark Details

Filing Date

August 24, 2016

Registration Date

July 17, 2018

Published for Opposition

January 30, 2018

Cancellation Date

January 31, 2025

Goods & Services

Dairy produce and dairy products, namely, dairy-based beverages, dairy-based powders for making dairy-based food beverages and shake and dairy-based spreads; milk products excluding ice cream, ice milk and frozen yoghurt; milk; milk powder other than for babies; milk protein and milk protein products; milk powder replacers in the nature of milk powder; preparations for making milk based beverages in the nature of powdered milk; prepared meals consisting primarily of meat, fruit or vegetables

Pharmaceutical preparations and substances, namely, skincare preparations and substances; pharmaceutical preparations derived from dairy sources for skin care and the treatment of eczema, psoriasis and other skin conditions; pharmaceutical preparations for the therapeutic treatment of diabetes; pharmaceutical preparations for skin care and pharmaceutical preparations for application to the skin for skin care, the treatment of eczema, psoriasis and other skin conditions; pharmaceutical preparations for the treatment of dermatitis; pharmaceutical preparations for boosting the immune system; pharmaceutical preparations and products for treatment of metabolic disorders; pharmaceutical preparations and substances whose primary purpose is to boost metabolism or fat burning; pharmaceutical agents for activating metabolism; dietary medical preparations for slimming purposes, including food supplements; dietary nutritional supplements not for medical purposes; dietetic substances, namely, dietetic foods adapted for medical use, including dietetic substances for use in weight control; dietetic foodstuffs for medical use in the form of prepared meals, namely, dietetic foods adapted for medical use; dietetic beverages adapted for medical purposes; dietetic additives for food, namely, meal replacements in the nature of powdered nutrition and protein supplements; meal supplements in the nature of dietary supplements and other formulated powdered preparations in the nature of glucose for use as an additive to foods for medical purposes; protein for dietetic purposes, namely, protein supplements; energy drinks in the nature of dietary supplemental drinks and energy drinks that are adapted for medical purposes, namely, dietary supplemental drinks; medicated preparations for use as additives for food for human consumption, namely, vitamin preparations for use as a supplement for dietary supplements and infant formula; foods for persons having complex metabolic disorders, namely, meal replacements in the nature of meal replacement bars adapted for medical use, meal supplements in the nature of nutritional supplement meal replacement bars for boosting energy, and other formulated powdered preparations, namely, powdered dietary supplements; foodstuffs for use in the dietary management of obesity, namely, special dietary foods, beverages and meal replacements in the nature of dietetic foods, namely, pasta adapted for medical use, meal replacement bars for weight loss purposes and meal replacement beverages adapted for medical use; health food supplements for persons with special dietary requirements; dried milk products for babies, namely, dried milk powder for babies; milk foods for babies; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds, namely, milk sugar for medical purposes; human milk oligosaccharide additives for use as nutritional supplements in connection with pharmaceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds, namely, milk sugar for medical use; health food supplements and mineral supplements, namely, mineral supplements for foodstuffs for human consumption; medicated mineral drinks, namely, medicated mineral spring waters; nutritional supplements, namely, nutritional supplements containing nut and fish oils; nutritional meal replacement powders in the nature of meal replacement powdered drink mixes adapted for medical use; nutritional meal replacements, namely, nutritional meal replacement bars, milkshakes and other powdered preparations adapted for medical use for individuals preparing for or undergoing medical treatments; non-carbohydrate dietary supplements other than for medical use; powdered dietary food concentrates in the nature of dietary supplement drink mixes; powdered dietary food concentrates in the nature of weight management supplements for use in weight reduction programmes for medical purposes; preparations for use as additives to food for consumption, namely, minerals and vitamin supplements; protein preparations in the nature of protein supplements for use as additives to foodstuffs for human consumption; protein based food preparations, being dietetic protein supplements and nutritional additives that are not for medical purposes in the nature of protein dietary supplements; slimming aids for medical use, namely, weight management products in the nature of dietary nutritional supplements; slimming preparations for medical use, namely, meal replacement shakes for weight loss purposes; slimming products for medical use, namely, stimulatory medications for use in weight reduction programmes; vitamins and vitamin supplements; none of the foregoing goods including cell lines, antibodies or proteins for pharmaceutical use

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 30, 2025 INTR
CANCELLED SECTION 71
Jan 31, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 17, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 16, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 30, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 30, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 29, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 14, 2018 OPNR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 10, 2018 ETOP
POST PUBLICATION AMENDMENT - ENTERED
May 16, 2018 CHPB
ASSIGNED TO PETITION STAFF
May 15, 2018 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 27, 2018 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 22, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jan 26, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 10, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 10, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 7, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 20, 2017 GNFN
FINAL REFUSAL E-MAILED
Jun 20, 2017 GNFR
FINAL REFUSAL WRITTEN
Jun 20, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2017 TROA
REFUSAL PROCESSED BY IB
Feb 18, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 19, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 17, 2017 MAFR
ASSIGNED TO EXAMINER
Jan 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2017 REPR